Skip to content
Riskpilot
← Back to search
Sign in
Get full access
UCB PHARMA AS
AS
Active
Org 976281918
Haakon Viis Gate 6, 0161
Oslo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1996
5 employees
Watchlist
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
UCB PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
74M
148M
222M
296M
257M
2020
250M
2021
231M
2022
228M
2023
249M
2024
EBITDA
NOK millions
0M
3M
5M
8M
10M
9M
2020
8M
2021
8M
2022
7M
2023
9M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
256 923
250 217
230 808
227 542
248 612
Staff expenses
−0
−0
−13 947
−12 516
−11 841
EBITDA
9 381
8 309
7 751
7 483
8 525
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
9 381
8 309
7 751
7 483
8 525
Net financials
−443
−440
−808
−1 552
−3 110
Profit before tax
8 938
7 869
6 944
5 931
5 415
Tax
1 987
1 953
1 717
1 538
1 790
Net profit
6 951
5 916
5 226
4 393
3 625
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
144 594
135 197
126 234
148 758
132 807
Equity
22 424
28 325
28 380
33 111
38 143
Long-term debt
0
0
0
0
0
Short-term debt
122 170
106 871
97 854
115 647
94 664
Total debt
122 170
106 871
97 854
115 647
94 664
Financial ratios
5-year trend
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
2020
2024
Equity ratio
28.7%
This company
38.2%
Market median
-25% vs market
2020
2024
Return on equity
9.5%
This company
18.4%
Market median
-48% vs market
2020
2024
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
2020
2024
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
2020
2024
Debt / equity
2.48×
This company
0.62×
Market median
-300% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on UCB PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
